Henit Yanai

4.7k total citations
125 papers, 2.6k citations indexed

About

Henit Yanai is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Henit Yanai has authored 125 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Genetics, 57 papers in Epidemiology and 43 papers in Surgery. Recurrent topics in Henit Yanai's work include Inflammatory Bowel Disease (93 papers), Microscopic Colitis (49 papers) and Gastrointestinal Bleeding Diagnosis and Treatment (14 papers). Henit Yanai is often cited by papers focused on Inflammatory Bowel Disease (93 papers), Microscopic Colitis (49 papers) and Gastrointestinal Bleeding Diagnosis and Treatment (14 papers). Henit Yanai collaborates with scholars based in Israel, United States and Italy. Henit Yanai's co-authors include Stephen B. Hanauer, Iris Dotan, Yulia Ron, Yehuda Chowers, Shomron Ben‐Horin, Adi Lahat, Uri Kopylov, Rami Eliakim, Idan Goren and Arie Levine and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Henit Yanai

115 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henit Yanai Israel	28	1.8k	1.3k	923	600	436	125	2.6k
Jarosław Kierkuś Poland	25	1.4k 0.7×	1.0k 0.8×	808 0.9×	815 1.4×	353 0.8×	186	2.7k
Vipul Jairath Canada	31	2.2k 1.2×	1.6k 1.2×	1.1k 1.2×	515 0.9×	214 0.5×	192	3.0k
Miguel Regueiro United States	25	2.4k 1.3×	1.8k 1.4×	1.3k 1.4×	416 0.7×	314 0.7×	184	3.4k
Ian C. Lawrance Australia	27	2.0k 1.1×	1.4k 1.1×	783 0.8×	643 1.1×	195 0.4×	85	2.9k
Parakkal Deepak United States	27	1.4k 0.7×	1.1k 0.8×	832 0.9×	397 0.7×	273 0.6×	209	2.5k
Taina Sipponen Finland	28	2.2k 1.2×	1.7k 1.3×	1.1k 1.2×	662 1.1×	295 0.7×	66	2.8k
Mariangela Allocca Italy	33	2.0k 1.1×	1.6k 1.2×	1.1k 1.1×	453 0.8×	320 0.7×	177	3.3k
Míriam Mañosa Spain	28	1.5k 0.8×	1.2k 0.9×	763 0.8×	348 0.6×	210 0.5×	129	2.2k
Jean-Paul Achkar United States	24	2.0k 1.1×	1.4k 1.1×	1.2k 1.3×	351 0.6×	495 1.1×	31	2.9k
Amanda Ricciuto Canada	17	1.7k 0.9×	1.3k 1.0×	849 0.9×	282 0.5×	200 0.5×	44	2.4k

Countries citing papers authored by Henit Yanai

Since Specialization

Citations

This map shows the geographic impact of Henit Yanai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henit Yanai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henit Yanai more than expected).

Fields of papers citing papers by Henit Yanai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henit Yanai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henit Yanai. The network helps show where Henit Yanai may publish in the future.

Co-authorship network of co-authors of Henit Yanai

This figure shows the co-authorship network connecting the top 25 collaborators of Henit Yanai. A scholar is included among the top collaborators of Henit Yanai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henit Yanai. Henit Yanai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boneh, Rotem Sigall, S Organ, Henit Yanai, et al.. (2025). P1323 Differential Microbiome Responses to the Crohn’s Disease Exclusion Diet in Pediatric vs. Adult Populations: Insights from Randomized Controlled Trials. Journal of Crohn s and Colitis. 19(Supplement_1). i2383–i2383.

Yanai, Henit, Amir Ben‐Tov, Tal Patalon, et al.. (2025). Incidence of Ocular Manifestation After Adult-Onset Inflammatory Bowel Disease: A 20-Year Population-Based Cohort Study. Inflammatory Bowel Diseases. 32(2). 220–227.

Ben‐Tov, Amir, Tal Patalon, Sivan Gazit, et al.. (2024). The Prevalence and Characteristics of Inflammatory Bowel Disease-related Ocular Involvement in Children. Inflammatory Bowel Diseases. 31(5). 1256–1262. 2 indexed citations

Avni‐Biron, Irit, Ervin Tóth, Jacob E. Ollech, et al.. (2024). The Role of Small-Bowel Capsule Endoscopy in the Diagnostic Algorithm of Complicated Perianal Disease. Diagnostics. 14(16). 1733–1733. 1 indexed citations

Godny, Lihi, Ian White, Nir Wasserberg, et al.. (2024). Factors Associated With Biologic Therapy After Ileal Pouch–Anal Anastomosis in Patients With Ulcerative Colitis. Inflammatory Bowel Diseases. 31(7). 1934–1942. 1 indexed citations

Konikoff, Tom, Henit Yanai, Uri Kopylov, et al.. (2024). Precision medicine: Externally validated explainable AI support tool for predicting sustainability of infliximab and vedolizumab in ulcerative colitis. Digestive and Liver Disease. 56(12). 2069–2076.

Atia, Ohad, Shira Greenfeld, Revital Kariv, et al.. (2024). Predictors of Complicated Disease Course in Adults and Children With Crohn’s Disease: A Nationwide Study from the epi-IIRN. Inflammatory Bowel Diseases. 30(12). 2370–2379. 3 indexed citations

Atia, Ohad, Shira Greenfeld, Revital Kariv, et al.. (2024). Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis: A Nationwide Study From the epi-IIRN. Inflammatory Bowel Diseases. 31(3). 655–664. 3 indexed citations

Ben‐Horin, Shomron, Nir Salomon, N. Viazis, et al.. (2023). P560 Curcumin-QingDai combination for patients with active ulcerative colitis: A randomized double-blinded placebo-controlled trial. Journal of Crohn s and Colitis. 17(Supplement_1). i691–i691. 2 indexed citations

10.

Fidalgo, Catarina, A Walsh, Michel Adamina, et al.. (2023). OP19 Gaps between ECCO quality standards of care and the real world: the E-QUALITY survey. Journal of Crohn s and Colitis. 17(Supplement_1). i26–i27. 2 indexed citations

11.

Albshesh, Ahmad, Marie Truyens, Stephan R. Vavricka, et al.. (2023). Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn’s Disease: A Multi-Center Retrospective Cohort Study. Journal of Clinical Medicine. 12(7). 2503–2503. 4 indexed citations

12.

Atia, Ohad, Idan Goren, Shira Greenfeld, et al.. (2023). 5‐aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease—A nationwide cohort study. Alimentary Pharmacology & Therapeutics. 57(9). 1004–1013. 12 indexed citations

13.

Atia, Ohad, Shira Greenfeld, Revital Kariv, et al.. (2023). Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRN. Inflammatory Bowel Diseases. 30(2). 213–221. 6 indexed citations

14.

Avni‐Biron, Irit, Eran Hadar, Michal Neeman, et al.. (2022). SARS-CoV-2 IgG Antibody Levels in Women with IBD Vaccinated during Pregnancy. Vaccines. 10(11). 1833–1833. 1 indexed citations

15.

Avni‐Biron, Irit, Eran Zittan, Uri Kopylov, et al.. (2022). Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study. Alimentary Pharmacology & Therapeutics. 56(9). 1361–1369. 24 indexed citations

16.

Atia, Ohad, Esther Orlanski‐Meyer, Shira Greenfeld, et al.. (2021). Improved Outcomes of Paediatric and Adult Crohn’s Disease and Association With Emerging Use of Biologics–A Nationwide Study From the Epi-IIRN. Journal of Crohn s and Colitis. 16(5). 778–785. 19 indexed citations

17.

Atia, Ohad, Esther Orlanski‐Meyer, Shira Greenfeld, et al.. (2021). Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN. Journal of Crohn s and Colitis. 16(5). 796–803. 30 indexed citations

18.

Kopylov, Uri, Irit Avni‐Biron, Yulia Ron, et al.. (2018). Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease—The Israeli real world experience. Digestive and Liver Disease. 51(1). 68–74. 21 indexed citations

19.

Yanai, Henit, Yulia Ron, Guy Rosner, et al.. (2017). Comparative Study of Two Cohorts of Newly Diagnosed Crohn's Disease Demonstrates Change in Therapeutic Strategies. Digestion. 96(3). 135–141. 4 indexed citations

20.

Yanai, Henit, Shay Ben‐Shachar, Gilad Gitstein, et al.. (2014). Gene expression alterations in ulcerative colitis patients after restorative proctocolectomy extend to the small bowel proximal to the pouch. Gut. 64(5). 756–764. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact